D. Zarca

402 total citations
9 papers, 118 citations indexed

About

D. Zarca is a scholar working on Cancer Research, Genetics and Reproductive Medicine. According to data from OpenAlex, D. Zarca has authored 9 papers receiving a total of 118 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cancer Research, 3 papers in Genetics and 3 papers in Reproductive Medicine. Recurrent topics in D. Zarca's work include Breast Cancer Treatment Studies (4 papers), BRCA gene mutations in cancer (3 papers) and Cancer Genomics and Diagnostics (3 papers). D. Zarca is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), BRCA gene mutations in cancer (3 papers) and Cancer Genomics and Diagnostics (3 papers). D. Zarca collaborates with scholars based in France, United States and Switzerland. D. Zarca's co-authors include Damienne Castaigne, M Prade, G Michel, CJH van de Velde, Vahit Özmen, Christos Markopoulos, Riccardo Masetti, Katie Breheny, Benjamin D. Pinder and Jeremy Braybrooke and has published in prestigious journals such as Gynecologic Oncology, European Journal of Surgical Oncology and European Journal of Cancer Care.

In The Last Decade

D. Zarca

8 papers receiving 113 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Zarca France	6	48	43	36	33	22	9	118
Sabrina Witherby United States	7	83 1.7×	27 0.6×	20 0.6×	7 0.2×	32 1.5×	11	188
T. Tillmanns United States	4	23 0.5×	18 0.4×	34 0.9×	26 0.8×	13 0.6×	10	168
Riccardo Rosso Italy	4	79 1.6×	37 0.9×	42 1.2×	13 0.4×	13 0.6×	5	128
Maria Grazia Razeti Italy	9	117 2.4×	27 0.6×	95 2.6×	9 0.3×	20 0.9×	17	232
Kalpana Ragupathy United Kingdom	6	71 1.5×	13 0.3×	67 1.9×	14 0.4×	19 0.9×	14	145
Raluca Nedelcu United States	4	35 0.7×	21 0.5×	126 3.5×	28 0.8×	16 0.7×	6	195
Jessica Marquard United States	8	36 0.8×	53 1.2×	51 1.4×	19 0.6×	8 0.4×	12	192
Philip Badman United Kingdom	4	43 0.9×	32 0.7×	78 2.2×	8 0.2×	12 0.5×	7	136
A.F. Olshan United States	5	61 1.3×	22 0.5×	7 0.2×	27 0.8×	26 1.2×	7	209
Ariane Darut‐Jouve France	7	86 1.8×	49 1.1×	8 0.2×	9 0.3×	33 1.5×	11	116

Countries citing papers authored by D. Zarca

Since Specialization

Citations

This map shows the geographic impact of D. Zarca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Zarca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Zarca more than expected).

Fields of papers citing papers by D. Zarca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Zarca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Zarca. The network helps show where D. Zarca may publish in the future.

Co-authorship network of co-authors of D. Zarca

This figure shows the co-authorship network connecting the top 25 collaborators of D. Zarca. A scholar is included among the top collaborators of D. Zarca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Zarca. D. Zarca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Mandel, Jean‐Louis, Bernard Baertschi, Damien Sanlaville, et al.. (2020). Réflexions éthiques sur le dépistage génétique préconceptionnel en population générale : le débat français et l’avis de la Société Française de Médecine Prédictive et Personnalisée. Ethics Medicine and Public Health. 12. 100439–100439.

Markopoulos, Christos, CJH van de Velde, D. Zarca, Vahit Özmen, & Riccardo Masetti. (2016). Clinical evidence supporting genomic tests in early breast cancer: Do all genomic tests provide the same information?. European Journal of Surgical Oncology. 43(5). 909–920. 37 indexed citations

Petit, Thierry, D. Zarca, Jean‐Marc Guinebretière, et al.. (2014). Utilisation de référentiels et hétérogénéité décisionnelle des indications de chimiothérapie adjuvante dans les cancers du sein exprimant les récepteurs hormonaux, HER2-négatifs: résultats d’un sondage national en France. Bulletin du Cancer. 101(10). 918–924. 7 indexed citations

Braybrooke, Jeremy, D. Zarca, Benjamin D. Pinder, et al.. (2014). Patients' experiences following breast cancer treatment: an exploratory survey of personal and work experiences of breast cancer patients from three European countries. European Journal of Cancer Care. 24(5). 650–661. 24 indexed citations

André, Fabrice, Suzette Delaloge, Jean‐Marc Guinebretière, et al.. (2013). Prolifération des cancers du sein et biomarqueurs décisionnels en pratique RPC (RPC 2013). ONCOLOGIE. 15(12). 594–604. 2 indexed citations

Zarca, D., et al.. (2009). 5167 French cost effectiveness study of the MammaPrint 70-gene signature in early stage breast cancer patients. European Journal of Cancer Supplements. 7(2). 310–310. 3 indexed citations

Ravina, J, et al.. (1990). Chemotherapy by the intravenous and intraperitoneal routes combined in ovarian cancer. Gynecologic Oncology. 36(2). 271–276. 8 indexed citations

Michel, G, D. Zarca, Damienne Castaigne, & M Prade. (1989). Secondary cytoreductive surgery in ovarian cancer.. PubMed. 15(3). 201–4. 30 indexed citations

Michel, G, Ferris M. Pfeiffer, Pierre Duvillard, et al.. (1989). [Sarcoma of the uterus. A clinical study apropos of 50 surgically treated cases at the Gustave Roussy Institute. Review of the literature].. PubMed. 18(8). 1024–30. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact